ArticlePharmaceuticals (Basel, Switzerland)2026

Preclinical Evaluation of Dual NOP/Mu Partial Agonists for Methamphetamine Use Disorder.

Thamires Righi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.